CVS stock rebounds after Medicare Advantage rate shock; what investors watch next
CVS Health shares rose 2.2% to $73.55 on Wednesday, recovering some ground after a 14% drop Tuesday sparked by a proposed 0.09% Medicare Advantage rate hike for 2027. The Centers for Medicare & Medicaid Services’ early proposal rattled managed-care stocks, with investors awaiting the final rate notice on April 6 and CVS’ earnings call on February 10.